Rosemary oil for hair growth: does the viral TikTok remedy actually work?

Why rosemary oil is everywhere right now

Scroll any hair-care corner of TikTok and you will hit it within minutes: rosemary oil, decanted into a dropper bottle or steeped into “rosemary water,” sold as the gentle, plant-based answer to thinning hair. The pitch is seductive because it is simple — a kitchen herb that does what a pharmacy drug does, without the prescription, the cost, or the scalp irritation. Most viral remedies collapse the moment you ask for the study behind them. This one is different, and that is exactly why it spread.

There is a study. In 2015, a team led by Panahi published a six-month randomized comparative trial that put rosemary oil directly against 2% minoxidil — the over-the-counter standard — in men with androgenetic alopecia (AGA), the medical name for male-pattern hair loss.¹ The headline result, that the two performed about the same on hair count, is the seed of the entire trend. Our job here is to take that result seriously without inflating it, because the gap between “one promising trial” and “proven equal of minoxidil” is where almost every honest reader gets misled. If you want the broader map of evidence-backed hair-growth actives, our hub on skin and aging tracks the rest of the field.

The mechanism: the signal rosemary pulls

Pattern hair loss is driven largely by dihydrotestosterone (DHT), a potent androgen that miniaturizes genetically susceptible follicles over time. DHT is produced from testosterone by an enzyme called 5-alpha-reductase. Block that enzyme and you blunt the signal that shrinks the follicle — which is precisely how the prescription drug finasteride works. The interesting part of rosemary’s story is that it appears to nudge the same lever, just far more weakly and from the outside.

In laboratory and animal work, Rosmarinus officinalis leaf extract inhibited 5-alpha-reductase activity by roughly 82% at 200 µg/mL and 95% at 500 µg/mL, and a specific constituent — 12-methoxycarnosic acid — was identified as the active compound.² In the same study, topical rosemary extract restored hair regrowth in mice whose hair cycling had been interrupted by testosterone. That is a clean mechanistic signal: the extract pulls on the DHT pathway and produces a visible hair effect in animals.

Rosemary appears to pull on the same DHT lever as finasteride — just far more weakly, and shown so far mostly in a dish and in mice, not in large human trials.

Two secondary signals are layered on top. Rosemary’s aromatic compounds have a vasodilatory, circulation-promoting effect, and better perfusion at the follicle means more oxygen and nutrients reaching the cells that build the hair shaft — the same broad rationale, incidentally, behind why scalp massage and minoxidil’s own vascular effects are thought to help. Rosemary also carries carnosic and rosmarinic acids, which damp inflammation and oxidative stress around the follicle.⁴ None of these three threads — anti-androgen, circulation, anti-inflammatory — is proven to be the operative mechanism in humans. They are mechanism-plausible, not yet trial-confirmed in people. That distinction is the whole reason this claim is graded Emerging rather than higher.

The one study everyone cites

Here is the trial, in full and without spin. Panahi and colleagues randomized 100 men with androgenetic alopecia to either rosemary oil (n = 50) or 2% minoxidil solution (n = 50), applied over six months, with standardized hair counts at baseline, three months, and six months.¹ The results were specific:

• At three months: no significant change in mean hair count in either group. Rosemary, like minoxidil, is slow.
• At six months: both groups showed a significant increase in hair count versus baseline — and there was no significant difference between the two groups. Rosemary held its own against the drug.
• On tolerability: scalp itching rose in both groups over time, but it was significantly more frequent with minoxidil than with rosemary at both check-ins.

Taken at face value, that is a striking result for a plant oil: comparable hair regrowth and a friendlier side-effect profile than the over-the-counter benchmark. It is the reason the trend has legs the way most do not. A 2025 review of herbal hair-loss remedies reaches the same cautious bottom line — rosemary was “as effective as minoxidil” in this trial, with fewer reported side effects — while explicitly flagging that the human evidence base is thin and that the supporting mechanistic work is short-term and animal-based.⁴

So why isn’t the grade higher? Because “one trial said so” is a sentence that should always trigger caution. The study is modestly sized, single-center, and — critically — has not been independently replicated in the decade since. There is no second randomized trial confirming the head-to-head, no larger multicenter version, and no long-term follow-up. In the evidence hierarchy, an unreplicated single RCT is genuinely promising but provisional. That is the textbook definition of Emerging.

Rosemary vs minoxidil: reading the comparison honestly

This is where the trend overreaches, and where the careful reading matters most. The Panahi trial compared rosemary to 2% minoxidil — the lower of the two over-the-counter strengths. And 2% is not the strong end of minoxidil’s own evidence. In a 393-man randomized trial, 5% minoxidil produced an earlier and larger response than 2%, which is why 5% became the workhorse dose for men.³ So “as good as 2% minoxidil” is a real but deliberately modest bar. It does not establish that rosemary matches 5% minoxidil, and it certainly does not establish parity with finasteride, which has a far deeper trial base.

The deeper asymmetry is the weight of evidence. Minoxidil is FDA-approved for hair loss precisely because it has been tested in many randomized, placebo-controlled trials across thousands of people, with dose-ranging data and long-term safety follow-up.³ Rosemary oil has one comparative trial and a small stack of mechanistic studies. Both can show hair growth; only one has been stress-tested by replication and regulators. Calling rosemary the overall equal of established treatments confuses a single encouraging result with a proven track record — which is why that specific claim grades Weak, even though the underlying head-to-head result is real.

If you want the contrast with another buzzy natural hair active that faces the same single-study problem, our companion read on copper peptides for hair growth walks through an almost identical evidence shape — promising mechanism, thin human data, big marketing.

Where it fits: a tiered view

We do not write protocols on this site — we write frameworks you take to a clinician. With that established, here is an honest way to place rosemary oil against your goals.

Grey areas: dilution, DIY, and the “product is not the plant” problem

Two grey areas decide whether any of the above applies to what you actually put on your scalp.

DIY is not the trial. The viral “rosemary water” — sprigs boiled in water and decanted into a spray bottle — and ad-hoc home dilutions are not standardized, and they are not what Panahi’s subjects used. Concentration of active compounds in a homemade brew is unknown and almost certainly far lower and less stable than a formulated oil. The 2025 review is blunt that optimal dosage and application methods for rosemary remain unestablished even for the studied product.⁴ Assuming DIY versions reproduce the trial result is the single biggest leap the trend asks you to make — and it grades Weak.

Low-risk is not no-risk. Topically and properly diluted, rosemary oil is well-tolerated — in the trial it actually caused less scalp itching than minoxidil.¹ That is the basis for the Moderate safety grade. But essential oils are sensitizers: allergic contact dermatitis to rosemary is documented, including a case traced specifically to its constituent carnosol.⁵ The practical rules are simple — never apply undiluted essential oil to the scalp, dilute into a carrier oil, patch-test on the forearm first, and stop if you develop redness, itching, or a rash. Ingesting rosemary oil is a different matter entirely and is not what any of this evidence addresses.

What we don’t know yet

The honest gaps are specific, not a vague “more research is needed”:

• No replication. There is no second independent randomized trial confirming the rosemary-vs-minoxidil result — the entire human case still rests on one study.¹
• No 5% comparison. Rosemary has never been tested against 5% minoxidil or against finasteride, so its place against the stronger standards is unknown.³
• No standardized product. Optimal concentration, formulation, and application frequency are unestablished even for the trial-grade oil, let alone DIY versions.⁴
• Thin data in women. The head-to-head was in men with AGA; female-pattern hair loss, which behaves differently, has not been tested the same way.
• No long-term durability data. Whether six-month gains hold, plateau, or fade over years is unstudied.

What this article is not saying

It is not saying rosemary oil is a proven equal of minoxidil — it is not. It is not telling anyone to stop a working treatment to chase a gentler one. And it is not endorsing the DIY rosemary-water version that dominates your feed, because that is not the thing that was studied. What it is saying is narrower and more useful: of all the natural remedies that go viral, rosemary oil is one of the very few with a real, on-point randomized trial behind it — genuinely promising, low-risk, and worth a careful try with eyes open, but a single unreplicated study, not the finished science.